1. Home
  2. RDY vs BLD Comparison

RDY vs BLD Comparison

Compare RDY & BLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • BLD
  • Stock Information
  • Founded
  • RDY 1984
  • BLD 2015
  • Country
  • RDY India
  • BLD United States
  • Employees
  • RDY N/A
  • BLD N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • BLD Engineering & Construction
  • Sector
  • RDY Health Care
  • BLD Consumer Discretionary
  • Exchange
  • RDY Nasdaq
  • BLD Nasdaq
  • Market Cap
  • RDY 11.6B
  • BLD 12.2B
  • IPO Year
  • RDY N/A
  • BLD N/A
  • Fundamental
  • Price
  • RDY $14.86
  • BLD $441.92
  • Analyst Decision
  • RDY Strong Buy
  • BLD Strong Buy
  • Analyst Count
  • RDY 2
  • BLD 11
  • Target Price
  • RDY $16.95
  • BLD $410.18
  • AVG Volume (30 Days)
  • RDY 1.1M
  • BLD 332.3K
  • Earning Date
  • RDY 10-24-2025
  • BLD 11-04-2025
  • Dividend Yield
  • RDY 0.48%
  • BLD N/A
  • EPS Growth
  • RDY 2.20
  • BLD 4.62
  • EPS
  • RDY 0.79
  • BLD 20.32
  • Revenue
  • RDY $3,897,394,052.00
  • BLD $5,216,155,000.00
  • Revenue This Year
  • RDY $7.33
  • BLD $1.11
  • Revenue Next Year
  • RDY $2.00
  • BLD $10.65
  • P/E Ratio
  • RDY $18.42
  • BLD $21.81
  • Revenue Growth
  • RDY 15.86
  • BLD N/A
  • 52 Week Low
  • RDY $12.26
  • BLD $266.26
  • 52 Week High
  • RDY $16.17
  • BLD $456.22
  • Technical
  • Relative Strength Index (RSI)
  • RDY 63.75
  • BLD 61.36
  • Support Level
  • RDY $14.00
  • BLD $434.91
  • Resistance Level
  • RDY $14.48
  • BLD $456.22
  • Average True Range (ATR)
  • RDY 0.20
  • BLD 12.51
  • MACD
  • RDY 0.08
  • BLD 3.30
  • Stochastic Oscillator
  • RDY 91.02
  • BLD 77.67

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About BLD TopBuild Corp.

TopBuild Corp is an installer and distributor of insulation products. Its operating segments involve the Installation and Specialty Distribution segment. The installation segment provides insulation installation services nationwide through contractor services business. Speciality Distribution segment distributes building and mechanical insulation, insulation accessories and other building product materials for the residential, commercial, and industrial end markets. The majority of revenue is earned from the installation segment. Its main customers are contractors. Other products include gutters, after-paint, garage doors, fireplaces, and fireproofing and stopping. TopBuild operates majorly in the United States.

Share on Social Networks: